We developed a group B streptococcus multiplex PCR assay which allows, by direct analysis of the amplicon size, determination of the surface protein antigen genes of alpha-C protein, epsilon protein, Rib, Alp2, Alp3, and Alp4. The multiplex PCR assay offers a rapid and simple method of subtyping Streptococcus agalactiae based on surface protein genes.
9, 10). For the protein subtyping, parallel PCRs using different primer pairs for each gene were set up; detection of epsilon gene had not previously been considered. We developed a multiplex PCR that allows determination of the following GBS surface protein genes directly by the analysis of the amplicon size: the alpha-C protein, the epsilon protein, Rib, Alp2/3, and Alp4.
While the repeats present extensive homology between alpha-protein-like proteins, the N-terminal portion is distinctive. The analysis of a ClustalW amino acid multisequence alignment of the N-terminal portions of the alpha-C and epsilon proteins, Rib, Alp2, Alp3, and Alp4 identified distinctive strings for each protein (Fig. 1) , except for the Alp2 and Alp3 proteins, which are identical over the first half of their length.
Primer nucleotide sequences corresponding to the distinctive strings were used in a multiplex assay as the reverse primers, while a nucleotide string, common to all the surface protein genes, was used as the forward primer (Table 1) . Briefly, total DNA preparations were prepared from GBS cultures, according to the instructions provided with a DNeasy tissue kit (QIAGEN), and 50 ng was used as a template in a final volume of 25 l of PCR mixture containing the following: 1ϫ PCR buffer; 2 mM MgCl 2 ; 200 M concentrations of dATP, dCTP, dGTP, and dTTP; 400 nM concentrations of each of the six primers; and 0.25 U of TaqDNA polymerase (Life Technologies).
The samples were amplified on a DNA thermal cycler (MJ Research, Inc.) by heating for 3 min at 96°C, followed by 30 cycles of 95°C for 60 s, 58°C for 45 s, and 72°C for 45 s and concluding with a cycle of 72°C for 10 min.
The PCR products were analyzed by electrophoresis in a 2% (wt/vol) agarose-1000 gel (Life Technologies). UV transillumination of the bands on the agarose gel showed different sizes of amplicons, which allowed direct identification of the surface protein gene possessed by each GBS strain tested (Fig. 2) .
A serologically typed collection of GBS reference strains (10 strains), selected clinical isolates (55 strains), and bovine strains (9 strains) was analyzed by multiplex PCR, and results derived from the direct analysis of amplicon size were correlated with the gene sequence of the corresponding amplified product for each individual strain ( Table 2 ). As noted above, C and R antisera cross-reacted with different protein genes. Moreover, as previously reported (4, 10), GBS strains can possess an alpha-protein-like protein gene even if the protein is not expressed on the surface. In two cases (reference strain Prague 10/84 and a bovine strain), no surface protein gene was detected. The absence of a surface protein gene in GBS isolates, although rare, has previously been reported (10) .
Relationships between serotypes and surface protein genes were noted but to a lesser degree than previously reported (10, 12) . The association of serotypes Ia, Ib, and II with the alpha protein, of serotype III with Rib, and of serotypes V and VIII with Alp3 was found, but these associations were not absolute. In particular, the alpha protein was present in most serotypes, Rib was detected in serotypes II, V, and VIII as well as in nontypeable strains, and Alp3 was also present in serotype VII. The Alp2 protein, first detected in serotype V (12) and subsequently detected in serotypes Ia and III (10), was also associated with type VIII in our study. No epidemiological studies surveyed the distribution of the epsilon protein that, in our study, was evenly distributed among GBS serotypes and prevalent in bovine strains.
The possibility of looking at the protein gene profile increases the potential of GBS subtyping by limiting the use of C and R antisera to the most appropriate strains after PCR has been used to ascertain protein expression.
A glycoconjugate vaccine to prevent GBS disease is being tested in clinical trials (1, 17) . Promising data on using GBS surface proteins as protein carriers instead of tetanus toxoid have been published (6, 13) . In this context, it is extremely important to have a rapid and reliable molecular test capable 
